Cardinal Health Receives Average Rating of “Buy” from Analysts (NYSE:CAH)
Cardinal Health (NYSE:CAH) has been given an average recommendation of “Buy” by the nineteen brokerages that are currently covering the stock, American Banking News.com reports. Three analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $77.93.
In other Cardinal Health news, CFO Jeffrey William Henderson sold 26,567 shares of Cardinal Health stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $72.63, for a total transaction of $1,929,561.21. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Cardinal Health (NYSE:CAH) opened at 73.27 on Monday. Cardinal Health has a one year low of $49.65 and a one year high of $74.40. The stock’s 50-day moving average is $71.62 and its 200-day moving average is $69.88. The company has a market cap of $24.667 billion and a price-to-earnings ratio of 21.51.
Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.25 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.3425 per share. This represents a $1.37 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend is Monday, September 29th.
Several analysts have recently commented on the stock. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday, August 18th. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.